{
 "name": "新穎生醫",
 "slug": "tw-6810",
 "aliases": [
  "新穎生醫股份有限公司",
  "BPM",
  "6810"
 ],
 "ticker": "6810",
 "industry": "生技醫療業",
 "website": "https://www.bpmbiotech.com/",
 "summary": "新穎生醫（6810）是興櫃的生技醫療類股公司，2014 年成立，2021 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "新穎生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "BPM",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2021-08-30",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2014-06-25",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "曾錙翎",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "曾錙翎",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 494485000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.bpmbiotech.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：DNlite-IVD103（遠腎佳）",
   "value": "預測第二型糖尿病患者腎功能惡化、腎移植預後監控｜兩個適應症同獲SFDA上市許可｜沙烏地阿拉伯",
   "unit": "",
   "as_of": "2023-12-08",
   "source": "https://www.bpmbiotech.com/tw/news/content/dnlite_ivd103%E4%BA%8C%E9%81%A9%E6%87%89%E7%97%87%E5%90%8C%E7%8D%B2%E6%B2%99%E7%83%8F%E5%9C%B0%E9%98%BF%E6%8B%89%E4%BC%AF%E4%B8%8A%E5%B8%82%E8%A8%B1%E5%8F%AF",
   "note": "公司當日官方稿明列同一國家兩張上市許可；不外推台灣或歐盟的核准適應症。"
  },
  {
   "claim": "催化劑：DNlite-IVD103",
   "value": "DNlite之CREDENCE分析於ASN Kidney Week口頭發表（FR-OR039）｜2026-10-23｜已公告",
   "unit": "",
   "as_of": "2026-10-20",
   "source": "https://www.bpmbiotech.com/tw/news/content/%E6%96%B0%E7%A9%8E%E7%94%9F%E9%86%AB%E6%94%9C%E6%89%8B%E7%AD%96%E7%95%A5%E5%A4%A5%E4%BC%B4_precision_diabetes_%E5%8F%83%E5%8A%A0_2026_%E7%BE%8E%E5%9C%8B%E8%85%8E%E8%87%9F%E9%86%AB%E5%AD%B8%E6%9C%83%E5%B9%B4%E6%9C%83__asn_kidney_week_",
   "note": "公司公告、丹佛當地時間；不是發表已完成或產品核准。"
  },
  {
   "claim": "催化劑：DNlite POCT",
   "value": "DNlite POCT陸續獲證（最快時程）｜2026Q4（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-04-22",
   "source": "https://www.bpmbiotech.com/uploads/images/Investor/ShareholderServices/%E6%B3%95%E4%BA%BA%E8%AA%AA%E6%98%8E%E6%9C%83_2026.pdf",
   "note": "2026-04-22官網法說列表對應PDF，第9、18頁；不是已獲證。未將Q3 CLIA預定商轉當已完成。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6810.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}